Community health centers argue 340B
rule is unnecessary and harmful
|
Providers argue
the Trump administration's plan to lower insulin and Epi-Pen costs for
community health center patients is unnecessary and could do more harm than
good. It could also be difficult to put into practice. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Wednesday, October 28, 2020
Community health centers argue 340B rule is unnecessary and harmful
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment